Contemporary use of ventricular assist devices

Annual Review of Medicine

Volumn 61, Issue , 2010, Pages 255-270

  Terracciano, Cesare M ^a   Miller, Leslie W ^b   Yacoub, Magdi H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Recovery; Remodeling; Transplantation

Indexed keywords

ACETYLSALICYLIC ACID; CLENBUTEROL; CLOPIDOGREL;

ANTICOAGULANT THERAPY; AORTA BALLOON; ASSISTED CIRCULATION; CARDIOVASCULAR EQUIPMENT; CELL THERAPY; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; GENE THERAPY; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; STROKE; TREATMENT INDICATION; VASCULAR ACCESS DEVICE; EQUIPMENT DESIGN; HEART INFARCTION; HEART VENTRICLE REMODELING; PATHOLOGY;

EQUIPMENT DESIGN; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; VENTRICULAR REMODELING;

EID: 77951722146     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.032309.063018     Document Type: Review

References (99)

1. Am. Heart Assoc. 2009. Heart and stroke facts: 2006 update. http://www.americanheart.org
2. Br. Heart Found. 2009. http://www.heartstats.org
3. Stewart S, Wilkinson D, Hansen C, et al. 2008. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118:2360-2367
4. Mayosi BM. 2007. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 93:1176-1183
5. Nugent AW, Daubeney PE, Chondros P, et al. 2003. The epidemiology of childhood cardiomyopathy in Australia. N. Engl. J Med. 348:1639-1646
6. Lipshultz SE, Sleeper LA, Towbin JA, et al. 2003. The incidence of pediatric cardiomyopathy in two regions of the United States. N. Engl. J. Med. 348:1647-1655
7. Shahar E, Lee S, Kim J, et al. 2004. Hospitalized heart failure: rates and long-term mortality. J. Card. Fail. 10:374-379
8. Jessup M, Brozena S. 2003. Heart failure. N. Engl. J. Med. 348:2007-2018
9. Hunt SA, Abraham WT, Chin MH, et al. 2005. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112:e154-235
10. Taylor DO, Edwards LB, Boucek MM, etal. 2006. Registryofthe International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J. Heart Lung Transplant. 25:869-879
11. Aharon AS, Drinkwater DC Jr, Churchwell KB, et al. 2001. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann. Thorac. Surg. 72:2095-2101
12. Dasse KA, Gellman B, Kameneva M, et al. 2007. Assessment of hydraulic performance and biocompati-bility of a MagLev centrifugal pump system designed for pediatric cardiac or cardiopulmonary support. ASAIO J. 53:771-777
13. John R, Liao K, Lietz K, et al. 2007. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J. Thorac. Cardiovasc. Surg. 134:351-358
14. Henriques JP, Remmelink M, Baan J Jr, et al. 2006. Safety and feasibilityof elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am. J. Cardiol. 97:990-992
15. Thiele H, Lauer B, Hambrecht R, et al. 2001. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 104:2917-2922
16. Henriques JP, de Mol BA. 2008. New percutaneous mechanical left ventricular support for acute MI: the AMC MACH program. Nat. Clin. Pract. Cardiovasc. Med. 5:62-63
17. Mather PJ, Konstam MA. 2007. Newer mechanical devices in the management of acute heart failure. Heart Fail. Rev. 12:167-172
18. Greenberg B, Czerska B, Delgado RM, et al. 2008. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). Circulation 118:1241-1249
19. Pagani FD, Long JW, Dembitsky WP, et al. 2006. Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Ann. Thorac. Surg. 82:1413-1418
20. Birks EJ, Tansley PD, Yacoub MH, et al. 2004. Incidence and clinical management of life-threatening left ventricular assist device failure. J. Heart Lung Transplant. 23:964-969
21. Miller LW, Pagani FD, Russell SD, et al. 2007. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 357:885-896
22. Pagani FD, Miller LW, Russell SD, et al. 2009. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J. Am. Coll. Cardiol. 54:312-321
23. Morshuis M, El-Banayosy A, Arusoglu L, et al. 2009. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. Eur. J. Cardiothorac. Surg. 35:1020-1027
24. Tuzun E, Roberts K, Cohn WE, et al. 2007. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex. Heart Inst. J. 34:406-411
25. Cheng JM, den Uil CA, Hoeks SE, et al. 2009. Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur. Heart J. 30:2102-2108
26. Yacoub MH, Miller LW. 2008. Long-term left-ventricular-assist-device therapy is here to stay. Nat. Clin. Pract. Cardiovasc. Med. 5:60-61
27. Christiansen S, Klocke A, Autschbach R. 2008. Past, present, and future of long-term mechanical cardiac support in adults. J. Card. Surg. 23:664-676
28. Frazier OH, Benedict CR, Radovancevic B, et al. 1996. Improved left ventricular function after chronic left ventricular unloading. Ann. Thorac. Surg. 62:675-681
29. Rose EA, Gelijns AC, Moskowitz AJ, et al. 2001. Long-term mechanical left ventricular assistance for end-stage heart failure. N. Engl. J. Med. 345:1435-1443
30. Potapov EV, Stiller B, Hetzer R. 2007. Ventricular assist devices in children: current achievements and future perspectives. Pediatr. Transplant. 11:241-255
31. Kaczmarek I, Mair H, Groetzner J, et al. 2005. Mechanical circulatory support in infants and adults with the MEDOS/HIA assist device. Artif. Organs 29:857-860 (Pubitemid 43934129)
32. Gandhi SK, Huddleston CB, Balzer DT, et al. 2008. Biventricular assist devices as a bridge to heart transplantation in small children. Circulation 118:S89-93
33. Kilic A, Nolan TD, Li T, et al. 2007. Early in vivo experience with the pediatric Jarvik 2000 heart. ASAIO J. 53:374-378
34. Ruygrok PN, Esmore DS, Alison PM, et al. 2008. Pediatric experience with the VentrAssist LVAD. Ann. Thorac. Surg. 86:622-626
35. Lietz K, Long JW, Kfoury AG, et al. 2007. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116:497-505
36. Miller LW, Lietz K. 2006. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J. Heart Lung Transplant. 25:756-764
37. Lietz K, Long JW, Kfoury AG, et al. 2007. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116:497-505
38. Levy WC, Mozaffarian D, Linker DT, et al. 2006. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424-1433
39. Neaton JD, Normand SL, Gelijns A,etal. 2007. Designs for mechanical circulatory support device studies. J. Card. Fail. 13:63-74
40. Felker GM, Rogers JG. 2006. Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. J. Am. Coll. Cardiol. 47:930-932
41. Weber KT, Janicki JS. 1989. Pathogenesis of heart failure. Cardiol. Clin. 7:11-24
42. Yacoub MH. 2001. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur. Heart J. 22:534-540
43. Levin HR,OzMC, Chen JM,etal. 1995. Reversal ofchronic ventricular dilation inpatients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91:2717-2720
44. Frazier OH, Myers TJ. 1999. Left ventricular assist system asa bridge to myocardial recovery. Ann. Thorac. Surg. 68:734-741
45. Jacquet L, Zerbe T, Stein KL, et al. 1991. Evolution of human cardiac myocyte dimension during prolonged mechanical support. J. Thorac. Cardiovasc. Surg. 101:256-259
46. Mann DL, Willerson JT. 1998. Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far? Circulation 98:2367-2369
47. KinoshitaM, TakanoH,TakaichiS,et al. 1996. Influenceofprolonged ventricular assistanceonmyocardial histopathology in intact heart. Ann. Thorac. Surg. 61:640-645
48. Kinoshita M, Takano H, Taenaka Y, et al. 1988. Cardiac disuse atrophy during LVAD pumping. ASAIO Trans. 34:208-212
49. Nakatani S, McCarthy PM, Kottke-Marchant K, et al. 1996. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J. Am. Coll. Cardiol. 27:894-901
50. Barbone A, Holmes JW, Heerdt PM, et al. 2001. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 104:670-675
51. Klotz S, Deng MC, Stypmann J, et al. 2004. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann. Thorac. Surg. 77:143-149
52. MaybaumS, Mancini D,XydasS, etal. 2007. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115:2497-2505
53. Etz CD, Welp HA, Tjan TD, et al. 2007. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann. Thorac. Surg. 83:1697-1705
54. Zafeiridis A, Jeevanandam V, Houser SR, et al. 1998. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98:656-662
55. Terracciano CM, Harding SE, Adamson D, et al. 2003. Changes in sarcolemmal Ca entry and sarcoplas-mic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur. Heart J. 24:1329-1339
56. Terracciano CM, Hardy J, Birks EJ, et al. 2004. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109:2263-2265
57. Soppa GK, Barton PJ, Terracciano CM, et al. 2008. Left ventricular assist device-induced molecular changes in the failing myocardium. Curr. Opin. Cardiol. 23:206-218
58. Xydas S, Rosen RS, Ng C, et al. 2006. Mechanical unloading leads to echocardiographic, electrocardio-graphic, neurohormonal, and histologic recovery. J. Heart Lung Transplant. 25:7-15
59. Bruckner BA, Stetson SJ, Perez-Verdia A, et al. 2001. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J. Heart Lung Transplant. 20:457-464
60. Klotz S, Danser AH, Foronjy RF, et al. 2007. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J. Am. Coll. Cardiol. 49:1166-1174
61. Klotz S, Foronjy RF, Dickstein ML, et al. 2005. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112:364-374
62. Norton GR, Tsotetsi J, Trifunovic B, et al. 1997. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 96:1991-1998
63. Towbin JA. 2007. Scarring in the heart-a reversible phenomenon? N. Engl. J. Med. 357:1767-1768
64. 2+ cycling. Annu. Rev. Med. 59:13-28
65. Dipla K, Mattiello JA, Jeevanandam V, et al. 1998. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97:2316-2322
66. Heerdt PM, Holmes JW, Cai B, et al. 2000. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102:2713-2719
67. Ogletree-Hughes ML, Stull LB, Sweet WE, et al. 2001. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104:881-886
68. Harding JD, Piacentino V III, Gaughan JP, et al. 2001. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 104:1241-1247
69. Kohl P, Noble D. 2008. Life and mechanosensitivity. Prog. Biophys. Mol. Biol. 97:159-162
70. Knoll R, Hoshijima M, Hoffman HM, et al. 2002. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111:943-955
71. Mancini DM, Beniaminovitz A, Levin H, et al. 1998. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98:2383-2389 (Pubitemid 28549781)
72. de Jonge N, van Wichen DF, Schipper ME, et al. 2002. Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. J. Am. Coll. Cardiol. 39:963-969
73. Hill JA, Olson EN. 2008. Cardiac plasticity. N. Engl. J. Med. 358:1370-1380
74. Ritter M, Su Z, Xu S, et al. 2000. Cardiac unloading alters contractility and calcium homeostasis in ventricular myocytes. J. Mol. Cell Cardiol. 32:577-584
75. Kolar F,MacNaughton C, Papousek F, et al. 1995. Changesincalcium handlinginatrophic heterotopically isotransplanted rat hearts. Basic Res. Cardiol. 90:475-481
76. Rakusan K, Heron MI, Kolar F, et al. 1997. Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries. J. Mol. Cell Cardiol. 29:1045-1054
77. Welsh DC, Dipla K, McNulty PH, et al. 2001. Preserved contractile function despite atrophic remodeling in unloaded rat hearts. Am. J. Physiol. Heart Circ. Physiol. 281:H1131-36
78. Oriyanhan W, Tsuneyoshi H, Nishina T, et al. 2007. Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. J. Heart Lung Transplant. 26:16-23
79. Ito K, Nakayama M, Hasan F, et al. 2003. Contractile reserve and calcium regulation are depressed in myocytes from chronically unloaded hearts. Circulation 107:1176-1182
80. Soppa GK, Lee J, Stagg MA, et al. 2008. Prolonged mechanical unloading reduces myofilament sensitivity to calcium and sarcoplasmic reticulum calcium uptake leading to contractile dysfunction. J. Heart Lung Transplant. 27:882-889
81. Soppa GK, Smolenski RT, Latif N, et al. 2005. Effectsofchronic administration ofclenbuterol on function and metabolism of adult rat cardiac muscle. Am. J. Physiol. Heart Circ. Physiol. 288:H1468-76
82. Barton PJ, Felkin LE, Birks EJ, et al. 2005. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.Circulation 112:I46-50
83. Hall JL, Birks EJ, Grindle S, et al. 2007. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur. Heart J. 28:613-627
84. Wong K, Boheler KR, Bishop J, et al. 1998. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc. Res. 37:115-122
85. Soppa GK, Lee J, Stagg MA, et al. 2008. Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure. Cardiovasc. Res. 77:695-706
86. Birks EJ, Tansley PD, Hardy J, et al. 2006. Left ventricular assist device and drug therapy for the reversal of heart failure. N. Engl. J. Med. 355:1873-1884
87. Renlund DG, Kfoury AG. 2006. When the failing, end-stage heart is not end-stage. N. Engl. J. Med. 355:1922-1925
88. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. 2007. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 167:989-997
89. Dimmeler S, Zeiher AM, Schneider MD. 2005. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115:572-583
90. Murry CE, Soonpaa MH, Reinecke H, et al. 2004. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668
91. Lee J, Stagg MA, Fukushima S, et al. 2009. Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 296:H927-36
92. van Laake LW, Passier R, Doevendans PA, et al. 2008. Human embryonic stem cell-derived cardiomy-ocytes and cardiac repair in rodents. Circ. Res. 102:1008-1010
93. Menasche P, Alfieri O, Janssens S, et al. 2008. The Myoblast Autologous Grafting in Ischemic Cardiomy-opathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189-1200
94. Schneider MD, French BA. 1993. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation 88:1937-1942
95. Murtuza B, Suzuki K, Bou-Gharios G, et al. 2004. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl. Acad. Sci. USA 101:4216-4221
96. Eschenhagen T, Zimmermann WH. 2005. Engineering myocardial tissue. Circ. Res. 97:1220-1231
97. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ. Res. 91:517-524
98. Marx SO, Reiken S, Hisamatsu Y, et al. 2000. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101:365-376
99. 2+ cycling after left ventricular assist device support in the failing human heart. J. Am. Coll. Cardiol. 44:837-845